who may switch over from insulin injections to these tablets. This could lead to uncontrolled diabetes, especially in children. I approached the PM’s grievance cell as the State Drugs Controller ...

Some diabetes patients this year have had trouble finding their preferred insulin brands as major drug ... diabetes increasingly turn to weight loss drugs such as Ozempic and Mounjaro, part ...

Life with diabetes usually includes many injections of the blood ... meals that beta cells can. Instead, there are small highs and lows as long-acting insulin is released, Romeo says.

One major reason? The rise of abortion pills, which are now used in the majority of abortions in America. Every month, thousands of women in states where abortion is banned have been able to ...

But weight-loss specialists have warned that NHS obesity services are already struggling to deal with demand for these drugs, and that the injections should only be used as part of a wider ...

Eddie Van Halen struggled with addiction his entire life. After doctors gave him steroid pills to combat swelling after surgery to remove a brain tumor near the end of his life, the legendary ...

A new treatment combining ReCET and semaglutide eliminated insulin use in 86% of type 2 diabetes patients, improving natural insulin sensitivity. A new treatment combining ReCET and semaglutide could ...

For people with type 1 diabetes, that means multiple insulin injections a day ... only need to inject this smart insulin once a week, instead of several times a day. A lot of diabetes-related ...

The pharma company's stock gained after it filed for approval for its fast-acting insulin analog, Aspart injection, with India's drugs regulator the Drugs Controller General of India (DCGI). The ...

The sharp movement in the early deals was seen after the company announced that it had filed its fast-acting insulin analog, Aspart injection (ASPARAPID), with the Drug Controller General of India.

Wockhardt announced the filing of its fast-acting insulin analog, Aspart injection (ASPARAPID™), with the Drugs Controller General of India (DCGI). This significant milestone reflects Wockhardt's ...